Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Xtract One Technologies Inc. T.XTRA

Alternate Symbol(s):  XTRAF | T.XTRA.WT

Xtract One Technologies Inc. is a Canada-based technology-driven threat detection and security solution provider, leveraging artificial intelligence (AI) to provide secure patron access control experiences. The Company's segments include Platform and Xtract. The Platform segment develops and commercializes a platform of AI-powered threat detection technologies. The Xtract segment develops and commercializes advanced artificial intelligence solutions for customers. Its products include SafeGateway, SmartGateway and Xtract One View. Its Gateway product enables companies to covertly screen for weapons at points of entry without disrupting the flow of traffic. Its AI-based software allows venue and building operators to identify weapons and other threats inside and outside of facilities and receive intelligence for optimizing operations. Xtract One View, the Company's cloud-based platform, provides oversight of its customers entire fleet of Xtract One SmartGateways from one interface.


TSX:XTRA - Post by User

Post by JVJ24601on Feb 11, 2022 5:53pm
253 Views
Post# 34422156

Best part of being infinite’s by promoters…

Best part of being infinite’s by promoters…

They don't really see the facts presented by true investors ... numbers, data, facts ... the better inform investors who are on the fence.  I have my lot of shares, not looking to add more.  But if dilutive investment doesn't come in 30 days, it will be a closed down going/ out of business sale by end of May.

Glad to hear many of you have these numbers, and based on the very nebulous, innuendoe'd webinar today, I'm sure you all have a gut feeling.  I'd say follow your gut on this one. 

Go back, look at history.  It often repeats itself.  How similar and dissimilar was this shareholder webinar from the 3 or 4 in the past? 

A year in with PE and  we have $5.7m in sales from 12 platform clients with payment over 3 years ($2.7m) and 7 Xtract contracts for $3m over probably 2 year payout.  Burn rate a year is $12-13m on current revenues of $2.4m a year, and only $6.98M in cash....  these numbers don't lie, nor do they breakeven.  

A hell of a lot more Xtract contracts needed (but Datametrex seem to be snatching those right up) and a hell of a lot of platform sales are needed (Evolv is still snatching those up)

Potential clients beating down PATs doors?  Where...  I see 12 and various divisions of the Canadian government with 7 AI projects..  


If I was going to drop a dilutive capital investment of $50m with the outstanding 160m+ shares, I'd let this drop on March 15, and then come in. I'd know I'd get a deal of the century at $0.35-0.40per share and then can ride it up...  tgatcwould dilute it another 120-130m and I've be sitting pretty owning 35% of PAT... making some changes along the way. 

Mark your calendars...  March 15, we'll see $4.5m-5m in bank and projected sales from Q2close ( for end of Jan 31).  But by March 15 there will be another $1.5m burned.  Leaving $3m cash PLUS ANY NEW SALES, not including the $5.7m sales with 24-36 month payouts referenced above.

I am surprised this doesn't worry more people.   That investment prospectus has been out there since November with a refresh in January.  


This needs #1 PRIORITY, and not a side bar discussion / shareholder driven question in a shareholder webinar.  What am I missing???

<< Previous
Bullboard Posts
Next >>